<?xml version="1.0" encoding="UTF-8"?>
<p id="Par86">All 15 CMGs covering treatment recommended urgent administration of antibiotics on clinical suspicion of bacterial meningitis (Table 
 <xref rid="Tab7" ref-type="table">7</xref>). Thirty-three percent (
 <italic>n</italic> = 5/15) specified a time-frame for administration, ranging from within one [
 <xref ref-type="bibr" rid="CR2">2</xref>, 
 <xref ref-type="bibr" rid="CR5">5</xref>] to three [
 <xref ref-type="bibr" rid="CR34">34</xref>, 
 <xref ref-type="bibr" rid="CR36">36</xref>, 
 <xref ref-type="bibr" rid="CR37">37</xref>] hours. Forty-seven percent (
 <italic>n</italic> = 7/15) recommended pre-hospital antibiotics if the patient initially presents to a healthcare setting outside of a hospital. One CMG noted that there are no prospective clinical data on the relationship of the timing of antimicrobial administration to clinical outcome in patients with bacterial meningitis, but since it is a neurologic emergency, appropriate therapy is recommended as soon as possible after the diagnosis is considered likely [
 <xref ref-type="bibr" rid="CR44">44</xref>]. It was highlighted that the choice of antibiotics should be informed by risk factors for different aetiologies, such as age and risk of reduced susceptibility to penicillin and third-generation cephalosporins [
 <xref ref-type="bibr" rid="CR5">5</xref>]. This was reflected in the CMGs, though with variations in specification of at-risk groups. Most recommended a third-generation cephalosporin alone [
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR34">34</xref>–
 <xref ref-type="bibr" rid="CR36">36</xref>, 
 <xref ref-type="bibr" rid="CR38">38</xref>, 
 <xref ref-type="bibr" rid="CR39">39</xref>, 
 <xref ref-type="bibr" rid="CR44">44</xref>] or in combination with a penicillin for all adults [
 <xref ref-type="bibr" rid="CR2">2</xref>, 
 <xref ref-type="bibr" rid="CR23">23</xref>, 
 <xref ref-type="bibr" rid="CR37">37</xref>], “elderly” [
 <xref ref-type="bibr" rid="CR36">36</xref>] and over 50 [
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR39">39</xref>, 
 <xref ref-type="bibr" rid="CR44">44</xref>] or over 60 years [
 <xref ref-type="bibr" rid="CR2">2</xref>], due to higher risk of 
 <italic>L. monocytogenes</italic> infection in these risk groups [
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR34">34</xref>, 
 <xref ref-type="bibr" rid="CR36">36</xref>, 
 <xref ref-type="bibr" rid="CR39">39</xref>]. Most guidelines that provided recommendations for neonates recommended a third-generation cephalosporin plus penicillin [
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR20">20</xref>, 
 <xref ref-type="bibr" rid="CR23">23</xref>, 
 <xref ref-type="bibr" rid="CR24">24</xref>, 
 <xref ref-type="bibr" rid="CR35">35</xref>, 
 <xref ref-type="bibr" rid="CR38">38</xref>, 
 <xref ref-type="bibr" rid="CR40">40</xref>, 
 <xref ref-type="bibr" rid="CR44">44</xref>] or alternatively an aminoglycoside with penicillin [
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR35">35</xref>, 
 <xref ref-type="bibr" rid="CR38">38</xref>, 
 <xref ref-type="bibr" rid="CR44">44</xref>]. However, the age cut-off for these recommendations varied, ranging from 1 [
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR23">23</xref>, 
 <xref ref-type="bibr" rid="CR44">44</xref>], to 2 [
 <xref ref-type="bibr" rid="CR35">35</xref>], or 3 months of age [
 <xref ref-type="bibr" rid="CR20">20</xref>, 
 <xref ref-type="bibr" rid="CR24">24</xref>, 
 <xref ref-type="bibr" rid="CR38">38</xref>, 
 <xref ref-type="bibr" rid="CR40">40</xref>]. For older infants and children, there was consensus on the recommendations of a third-generation cephalosporin alone [
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR19">19</xref>–
 <xref ref-type="bibr" rid="CR21">21</xref>, 
 <xref ref-type="bibr" rid="CR23">23</xref>, 
 <xref ref-type="bibr" rid="CR34">34</xref>–
 <xref ref-type="bibr" rid="CR36">36</xref>, 
 <xref ref-type="bibr" rid="CR38">38</xref>]. The guideline by MSF recommended a cephalosporin in an epidemic context where 
 <italic>N. meningitides</italic> is the most likely pathogen, and addition of cloxacillin if associated skin or umbilical cord infection for all age-groups [
 <xref ref-type="bibr" rid="CR38">38</xref>]. 
</p>
